Overcoming a
Fundamental Constraint
in Human Health

International leader in OCT-guided coronary interventions; validated OCT with histopathology for stent-vessel assessment.
Former President, Italian Society of Invasive Cardiology; Co-Chair, EAPCI Scientific Program for ESC Congress; Fellow, European Society of Cardiology since 2004.
Author of 300+ peer-reviewed manuscripts.

Distinguished Clinical Leadership: Co-Director of Prisma Health Aortic Center, leading multidisciplinary care for complex aortic pathologies and endovascular interventions.
Clinical Associate Professor (Vascular Surgery, USC SOM Greenville) and Clinical Assistant Professor (Biomedical Engineering, Clemson),.
Author of 20+ peer-reviewed publications.

PhD in Biomedical Sciences (molecular neuroscience) and an MD.
Board-certified General Surgeon; completing specialized fellowship in Vascular Surgery at Prisma Health.
Authored multiple publications,  research spans molecular signaling, breast cancer therapy, and COVID-19-related thromboembolic events

Non-clinical development expert with extensive experience in design and management of preclinical programs integrating research, pharmacology, ADME and toxicology. Broad expertise in early drug development ranging from small molecules to biologics, vaccines to ATMPs.
Today director of The NCD Company that provides non-clinical drug development services to the pharmaceutical industry.

President and Chief Scientific Officer at CVPath Institute since 2024.
Former Assistant Professor of Medicine at Emory University, directing NIH- and AHA-funded basic and translational cardiovascular research.
Author of 100+ peer-reviewed articles, editorials, and reviews impacting cardiovascular science and clinical medicine.

Emeritus Professor of Surgery & Vascular Medicine at USC School of Medicine Greenville; Founder of Gray Vascular LLC.
Former Director of Endovascular Services at Prisma Health.
Editorial boards member of Annals of Vascular Surgery, Endovascular Today.
Past President, American Board of Vascular Medicine; Co-Chair of SCAI’s Peripheral Disease Committee.

Dr. Francisco Ujueta is a physician-scientist with expertise in cardiovascular and vascular medicine, clinical, and environmental research. Currently an Assistant Professor at Vanderbilt University Medical Center, he brings extensive clinical, academic, and research experience, with a focus on developing innovative therapies for cardiovascular disease, peripheral artery disease, and environmental risk factors.